CD19 and CD22 targeted CAR-T cell therapy

· Chongqing Precision Biotech Co., Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for CD19 and CD22 targeted CAR-T cell therapy, covering 2023-04-18 to 2023-04-18. Get the full timeline:

Most recent: Clinical Trial Update: CD19 and CD22 Targeted CAR-T Cell Therapy for Relapsed/Refractory B Cell Leukemia and Lymphoma [Phase 1, Phase 2]